Troy Lund, MD, PhD
Associate Professor, Department of Pediatrics

Contact Info
Associate Professor, Department of Pediatrics
Faculty Member, Division of Pediatric Blood and Marrow Transplantation & Cellular Therapy Program
BMT Specialist, Pediatric Blood and Marrow Transplant (BMT) Center
Team Member, Mucopolysaccharidosis (MPS) Center
Team Member, Leukodystrophy Center
Faculty, Masters Program in Stem Cell Biology
Pediatric Blood and Marrow Transplant Physician
MD, University of Minnesota Medical School, Minneapolis, MN
Residency in Pediatrics, University of Minnesota Medical School, Minneapolis, MN
Fellowship in Hematology/Oncology and Blood and Marrow Transplantation, University of Minnesota Medical School, Minneapolis, MN
PhD, Cancer Biology, University of South Florida - Moffitt Cancer Center, Tampa, FL
MS, Medical Sciences, University of South Florida School of Medicine, Tampa, FL
Summary
Dr. Lund is interested in the use of hematopoietic stem cell transplantation (HSCT) primarily for patients with inherited metabolic disorders, like Adrenoleukodystrophy (ALD), Hurler syndrome (MPS-1H), Hunter syndrome, Metachromatic Leukodystrophy, and others. He studies the onset of disease, biomarkers of disease, mechanism of disease, and how HSCT improves the disease process. His work both in his research laboratory and with his patients has created many new approaches to treatment, which will ultimately make HSCT safer and more effective. "Yes, we’re saving lives. But that’s not enough. I want to improve the quality of life for these kids, and that’s where I’m focusing my energy.”
Awards & Recognition
Research
Research Summary/Interests
Dr. Lund's research focuses improving the outcomes for all patients undergoing blood and marrow transplantation by increasing the speed at which hematopoietic stem cells reconstitute the immune system after transplant. He also works to increase our understanding the pathophysiological processes underlying inherited metabolic diseases. One area Dr. Lund is exploring is how an autoimmune reaction may trigger the cerebral form of adrenoleukodystrophy (cALD), the most serious form of ALD. This study represents the largest screening for immune-reactivity in cALD ever performed, and further research could help identify ALD patients with immune-reactivity prior to the onset of cALD.
Publications
Click here to see a complete list of Dr. Lund’s studies which have been published by academic and research journals.
Clinical
Specialties
- Umbilical cord blood transplant
- Bone marrow transplant
- Peripheral blood stem cell transplant
Clinics
Journey Clinic - Center for Pediatric Blood and Marrow Transplantation
Board Certifications
- American Board of Pediatrics
- American Board of Pediatric - Pediatric Hematology-Oncology
Clinical Interests
Adrenoleukodystrophy; Bone marrow transplant; Hurler syndrome; Peripheral blood stem cell transplant; Umbilical cord blood transplant
Hospital Privileges
M Health Fairview Masonic Children's Hospital; University of Minnesota Medical Center
Media
Video
Video
View Dr. Lund's talk on Stem cells get stuck, but eventually make it home.